Letter: Possible bone-marrow depression by Ara-A therapy for disseminated herpes zoster.
D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001089:Arabinose / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006562:Herpes Zoster / Q000188:drug therapy*; D006801:Humans; D009705:Nucleosides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000998:Antiviral Agents; D009705:Nucleosides; D001089:Arabinose; D000225:Adenine